Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Claritev Corporation provides healthcare information services and technology solutions, likely focused on revenue cycle management, claims processing, or healthcare data analytics for providers and payers. The company exhibits severe financial distress with negative operating margins of -149%, massive net losses, and negative shareholder equity, suggesting recent restructuring, impairments, or acquisition-related charges. Stock has declined 68% over six months, reflecting investor concerns about viability and path to profitability.
Generates revenue through recurring SaaS subscriptions for healthcare IT platforms, transaction-based fees for claims processing and revenue cycle services, and project-based professional services. The 74% gross margin suggests software-centric model with high incremental margins, but massive operating losses indicate unsustainable overhead structure, likely from sales/marketing burn, integration costs, or legacy system maintenance. Pricing power depends on switching costs and regulatory compliance requirements that lock in healthcare provider clients.
Path to profitability announcements - cost reduction targets, restructuring completion timelines
Customer contract wins or losses - particularly large health system implementations or payer partnerships
Revenue stabilization signals - quarterly revenue trends, customer retention rates, same-store growth
Balance sheet concerns - liquidity position, debt covenant compliance, potential equity dilution or bankruptcy risk
M&A speculation - potential acquisition by larger healthcare IT players (Epic, Cerner/Oracle, Veradigm) or private equity take-private
Technology obsolescence - legacy systems may be losing to cloud-native competitors like Veradigm, athenahealth, or niche AI-powered revenue cycle platforms
Regulatory changes in healthcare reimbursement (Medicare Advantage, prior authorization rules) could reduce demand for specific revenue cycle services
Consolidation among healthcare providers into larger systems that prefer enterprise-wide platforms from Epic or Cerner/Oracle
Market share loss to better-capitalized competitors who can invest in product innovation while CTEV cuts costs
Customer defections during financial distress as healthcare providers seek stable long-term technology partners
Inability to retain key technical talent due to stock price collapse and uncertainty, degrading product quality
Negative shareholder equity of -$108M (implied from -3.7x P/B) indicates balance sheet insolvency, likely from accumulated losses or impairments
Negative free cash flow and 1.21x current ratio suggest potential liquidity crisis within 12-18 months without capital infusion
Debt/Equity of -45.69 is mathematically distorted by negative equity but indicates overleveraged capital structure requiring restructuring
Going concern risk - auditors may issue qualification if liquidity deteriorates further, triggering covenant defaults
moderate - Healthcare IT spending is relatively defensive as providers require operational systems regardless of economic conditions, but discretionary IT projects and system upgrades are delayed during recessions. Hospital financial stress from lower patient volumes or reimbursement pressure can reduce IT budgets. The company's distressed state makes it more vulnerable to customer budget cuts than healthy competitors.
Rising rates negatively impact valuation multiples for unprofitable growth companies, compressing the stock's P/S ratio further from already-depressed 0.4x. Higher rates increase refinancing costs if debt matures, though negative equity suggests complex capital structure. Rate increases also pressure healthcare provider customers' capital budgets as financing costs for system implementations rise. For distressed situations, tighter credit conditions reduce access to rescue financing.
High exposure - The negative equity position, negative free cash flow, and severe operating losses indicate potential covenant violations or refinancing needs. Tightening credit spreads (rising BAMLH0A0HYM2) would increase borrowing costs and reduce access to capital markets for potential rescue financing. Customer credit quality matters as healthcare providers facing financial stress may delay payments, evidenced by working capital pressures.
Deep value/distressed investors and special situations funds seeking restructuring plays or takeout candidates. The -68% six-month decline and 0.4x P/S ratio may attract contrarian investors betting on turnaround execution or M&A. Not suitable for growth, income, or risk-averse investors given negative profitability, balance sheet insolvency, and high bankruptcy risk. Requires high risk tolerance and ability to analyze restructuring scenarios.
high - Small-cap distressed healthcare IT stock with $400M market cap exhibits extreme volatility, evidenced by -68% six-month drawdown. Illiquid trading likely amplifies price swings. Any restructuring announcements, customer contract news, or liquidity events will drive 20-40% single-day moves. Volatility will remain elevated until path to profitability becomes credible or strategic transaction occurs.
